ProCE Banner Activity


Partners in Care: Nursing Considerations for Managing Patients With CLL/SLL


On-demand webcast of expert faculty presentation and case discussions dedicated to the nursing perspective. Learn how to better manage your patients with chronic lymphocytic leukemia and small lymphocytic lymphoma.

Nurses: 1.00 Nursing contact hour

Released: January 29, 2024

Expiration: January 28, 2025



Josie Montegaard

Josie Montegaard, MSN, AGPCNP-BC

Nurse Practitioner
Dana-Farber Cancer Institute
Boston, Massachusetts

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner


Supported by educational grants from AstraZeneca Pharmaceuticals and Lilly.

AstraZeneca Pharmaceuticals


Target Audience

This program is intended for hematology/oncology nurses and other HCPs who care for patients with CLL/SLL.

Program Learning Goal

The goal of this program is to improve the knowledge and competence of learners in effort to optimize treatment for patients with Chronic Lymphocytic Leukemia (CLL).

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Identify critical molecular pathways involved in the pathogenesis of CLL/SLL and differences in efficacy and safety profiles of the agents targeting these pathways

  • Implement evidenced-based interventions to optimize outcomes for patients with CLL/SLL, including managing AEs, addressing medication adherence, and minimizing potential drug–drug interactions

  • Employ available resources to effectively engage patients in shared decision-making, cultivating a shared understanding of treatment goals and the risks and benefits of various CLL/SLL treatment options, considering the agent’s toxicity profile, prognostic variables, and patient’s comorbidities


Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity:

Primary Author

Josie Montegaard, MSN, AGPCNP-BC

Nurse Practitioner
Dana-Farber Cancer Institute
Boston, Massachusetts

Josie Montegaard, MSN, AGPCNP-BC: consultant/advisor/speaker: AbbVie, Beigene.

The planners and content peer reviewers from Clinical Care Options, LLC do not have any relevant financial relationships to disclose.

Instructions for Credit

Participation in this self-study activity should be completed in approximately 1 hour. To successfully complete this activity and receive credit, participants must follow these steps during the period from January 29, 2024, through January 28, 2025:

  1. Login or Sign Up for an account by clicking at the top of this page.
  2. Read the target audience, learning objectives, and faculty disclosures.
  3. View and study the content in its entirety.
  4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 65 and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the confirmation page. Records of all CME/CE activities completed can be found on the "My Certificates" page. There are no costs/fees for this activity.


This program has been made available online.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.


Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.


Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Nursing Continuing Professional Development

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 1 contact hour.